Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.
Cronos Group Inc (CRON) generates news across multiple fronts as a globally diversified cannabis company operating cultivation and distribution businesses on four continents. Investors tracking this stock encounter a distinct news mix shaped by the company's international footprint and the evolving regulatory landscape of the global cannabis industry.
Quarterly and annual earnings announcements provide insight into the company's Canadian licensed production operations, international distribution performance, and brand portfolio progress. These financial disclosures reveal how the company's vertically integrated model performs across different markets and product categories.
International expansion represents a significant news driver for Cronos. The company's operations in Canada, Germany, Israel, Australia, and other markets mean news flow often includes market entry announcements, distribution partnerships, and regulatory developments in multiple jurisdictions. Each new market represents both opportunity and complexity for investors to track.
Brand and product launches generate regular news as Cronos develops its portfolio including Lord Jones, Spinach, and SOURZ by Spinach. Product introductions, limited edition releases, and new format launches indicate how the company competes for consumer attention in competitive cannabis markets.
Strategic transactions and corporate developments—including acquisitions, partnerships, and capital raises—shape the company's growth trajectory. Given the capital-intensive nature of cannabis operations and ongoing industry consolidation, corporate action news warrants attention from shareholders and prospective investors.
Bookmark this page for convenient access to Cronos Group news coverage, from earnings reports to expansion announcements to product launches across the company's global operations.
Cronos (NASDAQ: CRON) announced on December 9, 2025 that a wholly‑owned subsidiary signed a definitive agreement to acquire CanAdelaar B.V., the largest company in the Netherlands’ adult‑use cannabis pilot (Wietexperiment).
Up‑front consideration is €57.5 million (US$67.0 million), roughly 1.4x LTM revenue and 2.4x LTM EBITDA, with an additional cash earnout equal to 0.5x normalized EBITDA in 2026 and 2027. Cronos said the deal will deliver a #1 market share in the Netherlands and support its borderless product strategy using existing genetics, R&D, and product development investments.
Cronos (NASDAQ: CRON) launched Lord Jones Live Resin Fusions™ pre-rolls in Canada on November 25, 2025, expanding the Lord Jones premium cannabis portfolio.
Each 0.5g pre-roll pairs single-sourced dried flower with terpene-rich pure live resin caviar, targets 42%+ THC potency, and includes a reusable ceramic tip for a cooler smoke. New strains available at select Canadian retailers are Durban Kush x Citrus Sap, Hell Fire OG x Cali Gas, and Sour Diesel x Orange Velvet. More details and the full collection are available at lordjones.ca.
Cronos Group (NASDAQ: CRON) reported Q3 2025 results with net revenue of $36.3M, up 6% year‑over‑year and 9% sequentially, driven by record sales in Israel where PEACE NATURALS is the top brand. Gross profit rose to $18.3M and Adjusted EBITDA was positive $5.7M. The company ended the quarter with an industry‑leading liquidity position of $824M in cash and short‑term investments. Spinach retained the #2 brand ranking in Canada and Lord Jones and PEACE NATURALS showed strong category positions. Cronos GrowCo expansion completed with new flower capacity coming online in Fall 2025; international ex‑Israel shipments were modest this quarter due to timing.
Cronos (NASDAQ: CRON) is reintroducing its limited-edition SOURZ by Spinach Caramel Green Apple flavor for the Fall and Halloween 2025 season. The rollout returns the original Caramel Green Apple 5-pack gummies and adds two new fall exclusives: a Fully Blasted Caramel Green Apple 10mg THC gummy and a Spinach Sweet Green Apple 1g Sativa vape infused with liquid diamonds.
The flavor first launched in Fall 2024; the seasonal products are available now across Canada. For product details and store availability, the company directs consumers to the Spinach website.
Cronos Group (NASDAQ: CRON) will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2025 at 8:30 a.m. ET. Senior management will discuss the company’s financial results and take questions after prepared remarks.
Participants must register to attend the call or webcast at https://ir.thecronosgroup.com/events-presentations. The company recommends dialing in 15 minutes early to avoid delays. A webcast replay will be archived on the company website.
Cronos (NASDAQ: CRON) announced on October 9, 2025 that its SOURZ by Spinach Fully Blasted gummies will be sold in new multipack formats featuring liquid diamond‑infused gummies.
Products will launch in 5‑pack (5 x 10mg THC) and 10‑pack (10 x 10mg THC; one 10mg THC|10mg CBD SKU) configurations across five core flavors and will be available now in Alberta, British Columbia, Manitoba, Newfoundland, Nova Scotia, Ontario, Prince Edward Island, and Saskatchewan.
Management highlighted that SOURZ by Spinach holds just over 20% market share and has ranked as the #1 edible in Canada since September 2024, positioning the multipacks as a convenience and value play for existing customers.
Cronos Group (NASDAQ: CRON) reported strong Q2 2025 results with net revenue increasing 21% year-over-year to $33.5 million. The company achieved its highest-ever international and Israel revenue, with PEACE NATURALS® maintaining its position as the top cannabis brand in Israel.
Key financial metrics include gross profit of $14.5 million (up 130% YoY), improved gross margin to 43%, and Adjusted EBITDA of $1.7 million. The company maintains a strong balance sheet with $834 million in cash and short-term investments.
Notable developments include Spinach® ranking as Canada's second most popular cannabis brand with 4.7% market share, completion of the Cronos GrowCo expansion, and a strategic C$25.2 million investment in High Tide Inc. The company also successfully resolved the Israeli anti-dumping duty issue and expanded PEACE NATURALS® into new international markets.
Cronos Group (NASDAQ: CRON) has scheduled its 2025 second quarter earnings conference call for Thursday, August 7, 2025 at 8:30 a.m. ET. The company's senior management will present financial results and conduct a Q&A session with the investment community.
Participants can register for the call and webcast through the company's investor relations website. To ensure timely participation, attendees are encouraged to dial in fifteen minutes before the scheduled start time. A replay of the webcast will be available on Cronos Group's website after the event.
High Tide Inc. (NASDAQ: HITI) has secured a $30 million convertible debt through a loan agreement with Cronos Group Inc. The junior secured loan bears a 4% annual interest rate and has a 5-year term. The debt is convertible into High Tide common shares at $4.20 per share.
As part of the deal, Cronos received a warrant exercisable into 3,836,317 common shares at $3.91 per share, representing a 25% premium to the 30-day VWAP. High Tide plans to use the capital for future acquisitions and organic growth, aiming to expand its Canadian store network beyond 300 locations. The company currently operates 202 Canna Cabana locations across Canada, making it the second-largest cannabis retailer globally by store count.
Cronos Group (NASDAQ: CRON) has announced its expansion into the Swiss medical cannabis market through a partnership with Dascoli Pharma AG. Under the agreement, Cronos will supply its PEACE NATURALS® branded cannabis flower products through Dascoli's established medical network in Switzerland.
The expansion includes five cannabis flower varieties: GMO Cookies, Space Cake, Atomic Sour Grapefruit, Sonic Lemon Fuel, and Wedding Cake. The PEACE NATURALS® brand is now available in seven international markets, including Australia, Canada, Germany, Israel, Malta, Switzerland, and the UK.
FAQ
What is the current stock price of Cronos Group (CRON)?
What is the market cap of Cronos Group (CRON)?
